… were estimated according to response status at days 14, 28, or 56 using the Kaplan-Meier
estimate restricted to patients alive at each response assessment time. Probabilities of NRM …

… of response. Herein, we analyzed serum levels of three prominent host disease status biomarkers
C-… of using host biomarkers to monitor early therapeutic response in leukemia patients. …

… measures of functional status could represent important … status can provide corroborative
evidence of important changes after therapy. In other patient populations with chronic diseases […

… Graft-versus-host disease (GVHD) is a common fatal complication of hematopoietic stem
cell transplantation (HSCT), where steroids are used as a treatment option. However, there are …

… -versus-Host Disease (GVHD) Consensus Response Criteria … Provisional definitions of
complete response, partial response… from the determination of response, updates to or addition of …

… , as reported previously, 6 that response status on day 14 of treatment (nonresponse vs
partial or complete response) strongly predicted nonresponse status on day 28 (odds ratio, 21.79…

… Graft-versus-host disease (GVHD) is a systemic disease and a … response against recipient
antigen-presenting cells. This leads to host tissue destruction and a varying systemic response…

… Chronic graft-vs-host disease (cGVHD) is a complication of allogeneic … -vs-host disease is
an inflammatory process which results from the transplanted immune system attacking the host’…

… the only potential cure for a variety of primarily malignant hematological diseases. One of
the major limitations for this therapy is graft vs. host disease (GvHD) which is a major cause of …

… Despite decades of research and improvements in post-transplant immunosuppressive
therapies, graft-versus-host disease (GVHD) remains a significant cause of morbidity and …